Nanotechnology for immuno-oncology

Antonia, S. J. et al. Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. N. Engl. J. Med. 377, 1919–1929 (2017). CAS  PubMed  Google Scholar  […]